Pfizer and BioNTech will not receive any money from the government unless their vaccine succeeds in large clinical trials and can be successfully manufactured, according to a Pfizer spokeswoman.Under the agreement, the government would also have an option to procure an additional 500 million doses.
Pfizer said the price for the additional doses would be negotiated separately if the U.S. orders them.The vaccine, if successful, will be made available to Americans at no cost, although their health insurance may be charged, the U.S.
department of Health and Human Services (HHS) said.Pfizer Chief Executive Albert Bourla has said the company intends to make a profit on the vaccine.